|
I just started in the Phase III clinical trial for Xeloda with or without Lapatinib. It seems designed for those who failed Herceptin. I drew the arm without the Lapatinib. They are seeking 600 or so for this study, and I hope it gains some publicity so it can increase in size.
Shell
|